Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Jackson

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Wellcome Open Research|August 26, 2022
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trialYing Zhao, Claire Keene, Rulan Griesel, et al.
Gynecologic Oncology|November 26, 2013
Metformin is associated with improved survival in endometrial cancerEmily M Ko, Paige Walter, Amanda Jackson, et al.
Gynecologic Oncology|April 1, 2014
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significanceEmily M Ko, Paige Walter, Leslie Clark, et al.
American Journal of Cancer Research|March 14, 2025
Early-phase clinical trials in the pandemic era: a four-year experience from an academic cancer centerKatie Moreland, Bethany Fuhrman, Kayla Webb, et al.
Plos Medicine|September 29, 2005
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaKaren I Barnes, David N Durrheim, Francesca Little, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeksClaire M Keene, Tali Cassidy, Ying Zhao, et al.
The New England Journal of Medicine|November 15, 2018
Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRISGraeme Meintjes, Cari Stek, Lisette Blumenthal, et al.
AIDS (London, England)|May 11, 2021
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimenClaire M Keene, Rulan Griesel, Ying Zhao, et al.
Sensors (Basel, Switzerland)|November 9, 2024
Assessment of Physiological Signals from Photoplethysmography Sensors Compared to an Electrocardiogram Sensor: A Validation Study in Daily LifeRana Zia Ur Rehman, Meenakshi Chatterjee, Nikolay V Manyakov, et al.
Cancer Research|August 5, 2008
A six-gene signature predicting breast cancer lung metastasisThomas Landemaine, Amanda Jackson, Akeila Bellahcène, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Wellcome Open Research|August 26, 2022
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trialYing Zhao, Claire Keene, Rulan Griesel, et al.
Gynecologic Oncology|November 26, 2013
Metformin is associated with improved survival in endometrial cancerEmily M Ko, Paige Walter, Amanda Jackson, et al.
Gynecologic Oncology|April 1, 2014
The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significanceEmily M Ko, Paige Walter, Leslie Clark, et al.
American Journal of Cancer Research|March 14, 2025
Early-phase clinical trials in the pandemic era: a four-year experience from an academic cancer centerKatie Moreland, Bethany Fuhrman, Kayla Webb, et al.
Plos Medicine|September 29, 2005
Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South AfricaKaren I Barnes, David N Durrheim, Francesca Little, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 27, 2023
Recycling Tenofovir in Second-line Antiretroviral Treatment With Dolutegravir: Outcomes and Viral Load Trajectories to 72 weeksClaire M Keene, Tali Cassidy, Ying Zhao, et al.
The New England Journal of Medicine|November 15, 2018
Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRISGraeme Meintjes, Cari Stek, Lisette Blumenthal, et al.
AIDS (London, England)|May 11, 2021
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimenClaire M Keene, Rulan Griesel, Ying Zhao, et al.
Sensors (Basel, Switzerland)|November 9, 2024
Assessment of Physiological Signals from Photoplethysmography Sensors Compared to an Electrocardiogram Sensor: A Validation Study in Daily LifeRana Zia Ur Rehman, Meenakshi Chatterjee, Nikolay V Manyakov, et al.
Cancer Research|August 5, 2008
A six-gene signature predicting breast cancer lung metastasisThomas Landemaine, Amanda Jackson, Akeila Bellahcène, et al.
Pageof 7